BTM-3566

N/A

Report date: 2025/04/10 10:51:25
NMEFirst In Class

Base Information

Drug NameBTM-3566
Drug Alias NameBTM-3566Btm-3566
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMetalloendopeptidase OMA1, mitochondrial agonists
TargetsMetalloendopeptidase OMA1, mitochondrial
Therapy Area/IndicationsSolid tumoursHematologic NeoplasmsLymphoma, Mantle-Cell +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesBantam Pharmaceuticals LLC
China Registration ClassN/A

Develop Information

Active CompaniesBantam Pharmaceuticals LLC
Inactive CompaniesN/A
Active IndicationsSolid tumoursHematologic NeoplasmsLymphoma, Mantle-Cell +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A